Featured Image of Top News Story: Good news for people newly diagnosed with MOGAD: Study finds low relapse risk

Good news for people newly diagnosed with MOGAD: Study finds low relapse risk

People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. Researchers from Kaiser Permanente in Southern California followed 69 children and adults diagnosed ...